Financials Oriola Oyj

Equities

OKDBV

FI0009014351

Pharmaceuticals

Market Closed - Nasdaq Helsinki 11:29:30 2024-04-26 am EDT 5-day change 1st Jan Change
0.963 EUR -1.43% Intraday chart for Oriola Oyj -7.40% -11.49%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 367.1 349.6 362.5 321.2 199.1 180.7 - -
Enterprise Value (EV) 1 486.7 476.6 463.3 297.5 178.5 152 152.8 180.7
P/E ratio 50.6 x 31.7 x 33.4 x -174 x -9.89 x 17.5 x 10.1 x 7.94 x
Yield 4.44% 1.58% 2% 3.45% 6.43% 7.96% 9% 10.4%
Capitalization / Revenue 0.21 x 0.19 x 0.19 x 0.21 x 0.13 x 0.12 x 0.11 x 0.11 x
EV / Revenue 0.28 x 0.26 x 0.25 x 0.2 x 0.12 x 0.1 x 0.1 x 0.11 x
EV / EBITDA 7.4 x 7.61 x 6.51 x 6.48 x 3.43 x 4.34 x 4.16 x 4.41 x
EV / FCF 7.77 x 18.7 x 26.9 x 3.68 x 29.7 x 4.89 x 12 x 13.4 x
FCF Yield 12.9% 5.35% 3.71% 27.2% 3.36% 20.4% 8.31% 7.44%
Price to Book 2.33 x 2.02 x 1.67 x 1.4 x 1.16 x 1.08 x 1.03 x 1.02 x
Nbr of stocks (in thousands) 181,401 181,313 181,348 181,377 181,399 181,411 - -
Reference price 2 2.025 1.902 2.005 1.740 1.088 0.9630 0.9630 0.9630
Announcement Date 2/7/20 2/18/21 2/18/22 2/16/23 2/16/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 1,721 1,801 1,882 1,516 1,494 1,552 1,586 1,660
EBITDA 1 65.8 62.6 71.2 45.9 52.1 35 36.74 41
EBIT 1 20.5 21 26.3 17.8 16.7 22 23.58 26
Operating Margin 1.19% 1.17% 1.4% 1.17% 1.12% 1.42% 1.49% 1.57%
Earnings before Tax (EBT) 1 10.1 14.3 14.7 6.9 -17.6 12.84 21.17 26.39
Net income 1 8 11.3 11.3 -2.4 -20.7 9.67 17.13 22.1
Net margin 0.46% 0.63% 0.6% -0.16% -1.39% 0.62% 1.08% 1.33%
EPS 2 0.0400 0.0600 0.0600 -0.0100 -0.1100 0.0550 0.0955 0.1213
Free Cash Flow 1 62.6 25.5 17.2 80.9 6 31.05 12.7 13.45
FCF margin 3.64% 1.42% 0.91% 5.34% 0.4% 2% 0.8% 0.81%
FCF Conversion (EBITDA) 95.14% 40.73% 24.16% 176.25% 11.52% 88.71% 34.56% 32.8%
FCF Conversion (Net income) 782.5% 225.66% 152.21% - - 321.1% 74.13% 60.87%
Dividend per Share 2 0.0900 0.0300 0.0400 0.0600 0.0700 0.0767 0.0867 0.1000
Announcement Date 2/7/20 2/18/21 2/18/22 2/16/23 2/16/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 499 372.7 394.6 480.9 374.2 354.7 383.6 352.6 386.6 375.1 399 370 400.5
EBITDA 23 21.7 10.8 10.5 4.7 7.1 7 8.1 8.4 7 - - -
EBIT 1 11.6 15 5.5 6.6 0.9 3.5 3.4 4.4 5.4 4 5 5 6
Operating Margin 2.32% 4.02% 1.39% 1.37% 0.24% 0.99% 0.89% 1.25% 1.4% 1.07% 1.25% 1.35% 1.5%
Earnings before Tax (EBT) 1 6.8 2.7 7.3 6.7 -9.8 1.5 1.5 -19.7 -0.9 -2 2 2.5 5
Net income 1 5.3 8.8 12 14.6 -37.9 1.1 1.2 -20.2 -2.8 -2.3 1.4 1.8 4
Net margin 1.06% 2.36% 3.04% 3.04% -10.13% 0.31% 0.31% -5.73% -0.72% -0.61% 0.35% 0.49% 1%
EPS 2 0.0300 0.0500 0.0700 0.0800 -0.2100 0.0100 0.0100 -0.1100 -0.0200 -0.0100 0.0100 0.0100 0.0200
Dividend per Share - - - - - - - - - - - - -
Announcement Date 2/18/22 4/28/22 7/22/22 10/27/22 2/16/23 4/27/23 7/21/23 10/31/23 2/16/24 4/25/24 - - -
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 120 127 101 - - - - -
Net Cash position 1 - - - 23.7 20.6 28.8 27.9 -
Leverage (Debt/EBITDA) 1.818 x 2.029 x 1.416 x - - - - -
Free Cash Flow 1 62.6 25.5 17.2 80.9 6 31.1 12.7 13.5
ROE (net income / shareholders' equity) 7.82% 6.9% 5.9% -1.1% -10.4% 5.67% 10.2% 14.3%
ROA (Net income/ Total Assets) 1.34% 1.08% 1% -0.23% -2.18% 0.28% 1.85% 2.47%
Assets 1 596.9 1,043 1,129 1,027 947.8 3,504 925.6 893.2
Book Value Per Share 2 0.8700 0.9400 1.200 1.240 0.9400 0.8900 0.9300 0.9500
Cash Flow per Share 2 0.4700 0.3200 0.2200 0.4300 0.0500 0.1500 0.1800 -
Capex 1 21.8 32.8 22.8 8.5 3.6 20.9 21.2 26.7
Capex / Sales 1.27% 1.82% 1.21% 0.56% 0.24% 1.34% 1.34% 1.61%
Announcement Date 2/7/20 2/18/21 2/18/22 2/16/23 2/16/24 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
0.963 EUR
Average target price
1.175 EUR
Spread / Average Target
+22.01%
Consensus